Neurologic complications of ovarian carcinoma
作者： Lauren E. Abrey , Josep O. Dalmau
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<127::AID-CNCR18>3.0.CO;2-7
关键词:
摘要: BACKGROUND Neurologic complications of ovarian carcinoma are uncommon and to the authors' knowledge full spectrum has not been delineated previously. METHODS The authors reviewed findings 121 neurologic consultations on 83 patients between 1993 1996; this represents 4% all seen at study institution in time period. RESULTS The most common reasons for consultation were altered mental status, pain, weakness, numbness, headache, seizure. Twenty-seven diagnosed metastatic disease, 14 cerebrovascular 4 paraneoplastic syndromes; however, iatrogenic (n = 38) comprised majority diagnoses. Greater than 50% improved neurologically after diagnosis treatment. CONCLUSIONS Neurologic disease accompanying may be more diverse recognized previously. Definitive treatment benefits patients. Cancer 1999;85:127–33. © 1999 American Society.
sci-hub.se 参考文章(20)
A N Gordon, C A Stringer, C M Matthews, D L Willis, J Nemunaitis, Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting. Journal of Clinical Oncology. ,vol. 15, pp. 1965- 1973 ,(1997) , 10.1200/JCO.1997.15.5.1965
A A Ashour, C F Verschraegen, A P Kudelka, J J Kavanagh, Paraneoplastic syndromes of gynecologic neoplasms. Journal of Clinical Oncology. ,vol. 15, pp. 1272- 1282 ,(1997) , 10.1200/JCO.1997.15.3.1272
J. Y. Delattre, G. Krol, H. T. Thaler, J. B. Posner, Distribution of Brain Metastases JAMA Neurology. ,vol. 45, pp. 741- 744 ,(1988) , 10.1001/ARCHNEUR.1988.00520310047016
FRANCESC GRAUS, LISA R. ROGERS, JEROME B. POSNER, Cerebrovascular complications in patients with cancer. Medicine. ,vol. 64, pp. 16- 35 ,(1985) , 10.1097/00005792-198501000-00002
James Ziegler, Paul Gliedman, Daniel Fass, Mark Beckman, Andreas Neophytides, Alan Steinfeld, Brain metastases from ovarian cancer. Journal of Neuro-oncology. ,vol. 5, pp. 211- 215 ,(1987) , 10.1007/BF00151224
Jacques Dauplat, Roberta K. Nieberg, Neville F. Hacker, Central nervous system metastases in epithelial ovarian carcinoma Cancer. ,vol. 60, pp. 2559- 2562 ,(1987) , 10.1002/1097-0142(19871115)60:10<2559::AID-CNCR2820601035>3.0.CO;2-7
Moshe Stein, Mariana Steiner, Baruch Klein, Dan Beck, Jack Atad, Abraham Kuten, Eliezer Robinson, Dorit Goldsher, Involvement of the central nervous system by ovarian carcinoma. Cancer. ,vol. 58, pp. 2066- 2069 ,(1986) , 10.1002/1097-0142(19861101)58:9<2066::AID-CNCR2820580917>3.0.CO;2-Q
Robert J. Mayer, Ross S. Berkowitz, C. Thomas Griffiths, Central nervous system involvement by ovarian carcinoma. A complication of prolonged survival with metastatic disease Cancer. ,vol. 41, pp. 776- 783 ,(1978) , 10.1002/1097-0142(197802)41:2<776::AID-CNCR2820410253>3.0.CO;2-E
Michael Deutsch, Daniel Beck, Dorith Manor, Joseph Brandes, Metastatic brain tumor following negative second-look operation for ovarian carcinoma. Gynecologic Oncology. ,vol. 27, pp. 116- 120 ,(1987) , 10.1016/0090-8258(87)90238-1
Guido Cavaletti, Graziella Bogliun, Laura Marzorati, Alessandra Zincone, Marta Marzola, Nicoletta Colombo, Giovanni Tredici, Peripheral neurotoxicity of taxol in patients previously treated with cisplatin Cancer. ,vol. 75, pp. 1141- 1150 ,(1995) , 10.1002/1097-0142(19950301)75:5<1141::AID-CNCR2820750514>3.0.CO;2-U